Business Context and Reporting Period
This Form 6-K filing by Eason Technology Ltd. covers the month of March 2026, specifically reporting on corporate governance changes effective March 18, 2026. The company is a foreign private issuer with principal executive offices in Hong Kong.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Resignation: Yuan Gao resigned from his position as a member of the Board of Directors effective March 18, 2026. The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
- Appointment: Haitao He was elected as a director, subject to renewal at the next annual general meeting. The Board determined Mr. He qualifies as an independent director under the NYSE American LLC Company Guide.
- Compensation: Mr. He will receive a monthly compensation of $10,000 for his service as a director.
Outlook, Risks, and Management Commentary
Management highlighted Mr. He's professional background, noting over 10 years of experience in the pharmaceutical industry, including marketing, sales channel development, and business operations. His experience includes roles at Sichuan Datong Xinhong Pharmaceutical Group and as General Manager of Midou Industry (Shanghai) Co., Ltd., where he developed pharmaceutical e-commerce platforms and supply chains. There are no family relationships between Mr. He and other officers or directors. No specific risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Confirm the effective date of Yuan Gao's resignation and Haitao He's appointment (March 18, 2026).
- Verify Mr. He's independence status under the NYSE American LLC Company Guide.
- Review the attached Exhibit 4.1 (Offer Letter) for complete terms of Mr. He's compensation and service.
- Note that this filing contains no financial data; investors should refer to recent Form 20-F filings for financial metrics.